Hiroshi Kusunoki, MD, PhD Department of Internal Medicine, Osaka Dental University Abstract 　The rise of social media has fundamentally transformed the governance challenges faced by universities, academic societies, and other public institutions. Decisions that were once managed largely within organizations can now rapidly become matters of public controversy, exposing institutions to intense external scrutiny and pressure. This article examines two recent Japanese cases: th

Takashi Miyaji, internal medicine Clinical Education and Training Center, Akita University Hospital 【Key points 】 •Key concepts emphasized by the Reconstruction Design Council included “solidarity” and the “responsibility of the working generation.” •Income tax, which allows for contributions based on individuals’ ability to pay, served as the main source of funding. •Policies should be aligned with public values and provide a clear direction for society as a whole. While tax

Tetsuya Tanimoto, MD. Chairman of Accessible Railway Medical Services Tetsuikai Medical Corporation. Director of Navitas Clinic Kawasaki In May, the drug-pricing policy announced by the Trump administration went beyond a simple reduction in U.S. drug prices and took on the nature of a global political and economic strategy. Its impact is expected to ripple across the entire global pharmaceutical system. Behind the policy, which aims to align U.S. drug prices with those of cou

Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute To explain it again, "Chokubi" is a term for doctors who go "straight" or “direct” (choku) into aesthetic medicine (bi) immediately after finishing their initial clinical residency, without first passing through a university medical department or a general hospital. Reports last year indicated that several hundred doctors annually are choosing this path. I (the author) have been interested in th

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Recently, it was announced that the “Enhanced Games” will be held in Las Vegas, USA, in May 2026. Participants may take part as subjects in clinical trials. Events such as sprinting, swimming, and weightlifting will be held, but what is particularly noteworthy is that athletes can choose from three options: 1. participating naturally without using any drugs, 2. participating unde

Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute In recent years, the breast cancer field, which the author is responsible for, has seen a continuous succession of new drug developments. In 2024, capivasertib ("Truqap") for hormone receptor-positive breast cancer with specific gene mutations (PIK3CA, AKT1, PTEN) was approved in March, sacituzumab govitecan ("Trodelvy") for triple-negative breast cancer in November, and datopotamab deruxtecan (

Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute "We are taking this drug off the market because we cannot prove its effectiveness." Cancer treatment drugs that were deemed this way in the United States are still used as "recommended treatments" in Japan. At least seven cases have been confirmed as of July 2023. This surprising fact was revealed by the authors' latest research, accepted for publication in “Investigational New Drugs” and is due

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Keywords: #Ministry of Health, Labour and Welfare, #National Medical Licensing Examination, #Doctor Shortage, #Aesthetic Clinics, #Doctor Maldistribution, #Cosmetic Surgery As the maldistribution of doctors exacerbates shortages in rural areas and certain specialties, the government has proposed measures to regulate the outflow of doctors to aesthetic clinics, which has been cited as o

东京大学 第一学期 理科 3 班，第一年 清水圭太 中国没有“保险”概念的情况 说白了，中国的社会保障制度落后于日本。在日本，如果你生病或感觉不适，通常可以以合理的费用接受医疗。 这得益于作为国家机构而建立的社会保障制度，该制度适用于日本的任何地方。 但在中国，此类社会保障制度的发展却比较滞后。尽管中国的目标是实现全民健康保险制度，但城市学生和农村所有人均可选择购买公共医疗保险。 特别是在农村地区，“保险”这个概念并不为民众所熟悉，花钱预防疾病或受伤的想法似乎很难理解。 然而，由于中国的特殊国情，患病人数不断增加。 访问中国评估大学现状 今年3月9日，我有幸访问了中国复旦大学公共卫生学院，并与姜庆五教授会面。 我随姜教授会见了王和兴教授和王继伟副教授，并在与他们指导的研究生交流时，听取了他们对中国面临的各种公共卫生挑战的看法。 因为我考虑今后当一名医生，所以想认识一位中国的医生，经医疗管理所上昌广教授介绍，我认识了姜教授。 目前东京大学有大量中国留学生，研究生的数量远远多于本科生。他们一般都很优秀。有“在中国剧烈竞争的入学考试中脱颖而出的

Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute Is there any influence from pharmaceutical companies on the medicines doctors prescribe? On August 10th, 2024, medical students and young doctors tackled this sensitive issue head-on at a symposium held at the 56th Japanese Society of Medical Education Conference held at Teikyo University. "56.9% of doctors meet with pharmaceutical companies at least once a week." The results of our questionna

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The new coronavirus vaccine "Costaive," developed by Meiji Seika Pharma (a subsidiary of Meiji Holdings), has garnered significant public attention. Social media is flooded with misinformation, including claims that vaccinated individuals can infect others through 'shedding'. Meiji has initiated defamation lawsuits against anti-vaccine groups that have led the spread of these falsehoods.

Tetsuya Tanimoto, M.D. Medical Governance Research Institute, Tokyo, Japan In spring 2023, our pharmaceutical conflicts of interest research group participated in an international conference in Bath, UK. There, we had the pleasure of meeting Professor Tom Fahey from the Royal College of Surgeons in Ireland. While Ireland is a small nation with an estimated population of 5.28 million in 2023, it boasts a young demographic and impressive economic metrics. According to the IMF,

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan However, this incident occurred in Fukushima, Mr. Munakata's home prefecture. Perhaps he had an interest due to it being about his hometown. He said, "Since a junior asked," and introduced me to an excellent female staff member. She came to the medical research lab at Tokyo University and spent about two hours listening to the situation. After hearing my explanation, she said, "It's not

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan I recently had the opportunity to revisit the 2006 arrest incident of an obstetrician at Fukushima Prefectural Ohno Hospital. This was due to assisting Yuria Iyano, a student from Yokohama City University Medical School, with her report. Ms. Iyano chose to study under Professor Suzuki at the Graduate School of Public Policy, University of Tokyo, as part of her external training curriculu

Accessible Rail Medical Services Tetsuikai, Navitas Clinic Kawasaki Tetsuya Tanimoto, MD Terumo’s regenerative medicine product for heart failure treatment, "HeartSheet," achieved the world’s first practical application and received manufacturing and marketing approval in Japan in September 2015. However, on July 19th, it was confirmed at the Ministry of Health, Labour and Welfare’s Pharmaceutical Affairs Council Subcommittee on Regenerative Medicine Products and Biological T